Hif-1 alpha metabolically reprograms recruited alveolar macrophages to promote lung repair
Hif-1 α 通过代谢重新编程招募的肺泡巨噬细胞以促进肺修复
基本信息
- 批准号:9309186
- 负责人:
- 金额:$ 54.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2018-02-14
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAddressAffectAlveolarAlveolar CellAlveolar MacrophagesAlveolusApoptosisBlood capillariesCapillary Endothelial CellCell ProliferationCellsCessation of lifeComplexDataDefectEmbryonic DevelopmentEndothelial CellsEndotheliumEnergy MetabolismEpithelialEpithelial CellsFunctional disorderGasesGenesGenetic TranscriptionGlycolysisHIF1A geneHealthHistologicHomeostasisHypoxia Inducible FactorImpairmentInflammationInjuryLifeLungMetabolicMetabolismMolecularMusOxidative PhosphorylationPathologicPathway AnalysisPlatelet-Derived Growth FactorPlayPneumoniaProcessProductionProliferatingRecoveryRecruitment ActivityRespiratory physiologyRoleSiteStable PopulationsStructureTestingTherapeutic InterventionTimeTissuesVascular Endothelial Growth FactorsWarburg EffectWild Type Mouseaerobic glycolysisalveolar epitheliumanaerobic glycolysiscapillarycell injurydifferential expressionfunctional restorationinflammatory lung diseaseinjuredlung injurylung repairmacrophagemeetingsmigrationmonocyteneutrophilprogramsrepairedresponse to injuryrestorationself-renewaltissue repairtooltranscriptome sequencing
项目摘要
PROJECT SUMMARY
Pneumonia and acute inflammatory diseases of the lungs affect over 450 million people worldwide each year
and result in over 4 million deaths. Pathologic hallmarks include neutrophil accumulation in the airspaces,
injury to alveolar epithelial and endothelial cells, and resultant loss of epithelial-capillary integrity with impaired
gas exchange. Accordingly, restoration of lung function requires repair of injured alveoli, replacement of injured
epithelial and endothelial cells, and re-establishment of capillary barrier function. Macrophages are recognized
as critical orchestrators of tissue repair, however the mechanisms that drive their programming are poorly
understood. During health the airspaces are occupied by a stable population of resident alveolar macrophages
(RAM) that arise during embryogenesis and self-renew throughout life. RAMs remain during inflammation but
are joined by recruited macrophages (RecMΦ) that arise from circulating monocytes. These RecMΦ remain in
the lung while lung structure and function are restored, and then undergo apoptosis leaving RAMs to once
again populate the healthy airspaces. The contributions provided by RAM and RecMΦ to alveolar repair are
largely unknown and represent an important barrier to advancement in the field. In order to address this unmet
need, our group performed time-resolved RNA sequencing on RAMs and RecMΦ isolated from LPS treated
mice during acute and resolving inflammation. Our data showed marked differences in the transcriptomal
profiles of RAMs and RecMΦ at all time points studied, with over 50% of genes differentially expressed.
Pathway analysis and functional studies demonstrated that RecMΦ produce high levels of epithelial and
endothelial proliferative factors and suggested that RecMΦ are key orchestrators of tissue repair. Studies
using CCR2 -/- mice, which have defects in monocyte migration and impaired accumulation of RecMΦ, further
supported this concept; LPS treated CCR2-/- and wild type mice had equivalent degrees of lung injury, but
CCR2-/- mice had reduced epithelial and endothelial proliferation and prolonged capillary barrier dysfunction.
Transcriptomal and metabolic analyses suggested that HIF-1α transcription and stabilization were increased in
RecMΦ and that HIF-1α induced metabolically reprograming the RecMΦ toward glycolysis. These data led us
to hypothesize that RecMΦ are essential orchestrators of epithelial and endothelial cell proliferation following
acute lung injury and that the relevant programming of RecMΦ is driven by HIF-1α and glycolytic energy
metabolism. This will be tested in three Specific Aims. 1) Test the hypothesis that recruited macrophages are
programed to stimulate proliferation of alveolar epithelial and endothelial cells following acute lung injury. 2)
Test the hypothesis that glycolytic metabolism in recruited macrophages promotes their production of epithelial
and endothelial proliferative factors and stimulates tissue repair. 3) Test the hypothesis that HIF-1α is
responsible for metabolic reprogramming of recruited macrophages with enhanced anaerobic glycolysis and
reduced oxidative phosphorylation.
项目摘要
肺的肺炎和急性炎症性疾病每年影响全球超过4.5亿人
并导致超过400万人死亡。病理标志包括中性粒细胞在空间中的积累,
肺泡上皮和内皮细胞的损伤,以及由于受损而导致的上皮毛细血管完整性的损失
天然气交换。根据肺功能的恢复,需要修复受伤的肺泡,更换受伤
上皮细胞和内皮细胞,以及毛细血管屏障功能的重新建立。巨噬细胞被认可
作为组织修复的关键编排,但是驱动其编程的机制很差
理解齿。在健康期间,空域被稳定的居民肺泡巨噬细胞占据
(RAM)在胚胎发生和自我更新过程中出现的(RAM)。公羊在炎症期间保留,但
由循环单核细胞引起的招募巨噬细胞(RECMφ)连接。这些收集保留在
肺结结构和功能时的肺恢复,然后进行凋亡,将RAM留给一次
再次填充健康的空间。 RAM和RECMφ为肺泡修复提供的贡献是
在很大程度上未知,代表了该领域发展的重要障碍。为了解决这个未定的
需要,我们的小组在RAM上进行了时间分辨的RNA测序,并从经过的LPS分离出来
急性和解决炎症期间的小鼠。我们显示的数据标志着转录组的差异
在所有时间点研究的RAM和RECMφ的轮廓,超过50%的基因表达了超过50%。
途径分析和功能研究表明,循环产生了高水平的上皮和
内皮增生剂,并建议recmφ是组织修复的关键编排者。研究
使用CCR2 - / - 小鼠,这些小鼠在单核细胞迁移和RECMφ加速度受损中存在缺陷,进一步
支持这个概念; LPS处理的CCR2 - / - 和野生型小鼠的肺损伤程度相等,但
CCR2 - / - 小鼠减少了上皮和内皮增殖,毛细血管屏障功能障碍延长。
转录组和代谢分析表明,HIF-1α转录和稳定在
RECMφ并认为HIF-1α诱导代谢重新编程,以糖酵解的糖酵解。这些数据导致我们
假设recmφ是上皮和内皮细胞增殖的必要编排者
急性肺损伤,相关的RECMφ编程是由HIF-1α和糖酵解能驱动的
代谢。这将以三个具体目标进行测试。 1)检验招募巨噬细胞的假设是
编程以刺激急性肺损伤后肺泡上皮和内皮细胞的增殖。 2)
检验以下假设,即招募巨噬细胞中的糖酵解代谢会促进其上皮的产生
和内皮增生剂并刺激组织修复。 3)检验HIF-1α的假设
负责用厌氧性糖酵解和
氧化物磷酸化降低。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Apoptotic cell clearance and fibrotic lung disease.
- DOI:10.1183/09031936.00020612
- 发表时间:2012-08
- 期刊:
- 影响因子:0
- 作者:Janssen WJ;Morimoto K
- 通讯作者:Morimoto K
Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin.
- DOI:10.3109/01902148.2014.938202
- 发表时间:2014-10
- 期刊:
- 影响因子:1.7
- 作者:Yunt ZX;Mohning MP;Barthel L;Kearns MT;Tuder RM;Hyde DM;Henson PM;Janssen WJ
- 通讯作者:Janssen WJ
Neutrophil-mediated T-Cell Suppression in Influenza: Novel Finding Raising Additional Questions.
流感中中性粒细胞介导的 T 细胞抑制:新发现引发了更多问题。
- DOI:10.1165/rcmb.2017-0425ed
- 发表时间:2018
- 期刊:
- 影响因子:6.4
- 作者:Zemans,RachelL
- 通讯作者:Zemans,RachelL
Defective efferocytosis by alveolar macrophages in IPF patients.
- DOI:10.1016/j.rmed.2012.08.020
- 发表时间:2012-12
- 期刊:
- 影响因子:4.3
- 作者:Morimoto, Konosuke;Janssen, William J.;Terada, Mayumi
- 通讯作者:Terada, Mayumi
Selective and inducible targeting of CD11b+ mononuclear phagocytes in the murine lung with hCD68-rtTA transgenic systems.
使用 hCD68-rtTA 转基因系统选择性和诱导性靶向小鼠肺中的 CD11b 单核吞噬细胞。
- DOI:10.1152/ajplung.00141.2016
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:McCubbrey,AlexandraL;Barthel,Lea;Mould,KaraJ;Mohning,MichaelP;Redente,ElizabethF;Janssen,WilliamJ
- 通讯作者:Janssen,WilliamJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Janssen其他文献
William Janssen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Janssen', 18)}}的其他基金
Aspen Lung Conference: Bridging the Gap between Innate and Adaptive Immunity in the Lung
阿斯彭肺部会议:弥合肺部先天免疫和适应性免疫之间的差距
- 批准号:
10469141 - 财政年份:2022
- 资助金额:
$ 54.99万 - 项目类别:
Lung Macrophage Programming in Acute Lung Injury
急性肺损伤中的肺巨噬细胞编程
- 批准号:
10335239 - 财政年份:2018
- 资助金额:
$ 54.99万 - 项目类别:
Lung Macrophage Programming in Acute Lung Injury
急性肺损伤中的肺巨噬细胞编程
- 批准号:
10225232 - 财政年份:2018
- 资助金额:
$ 54.99万 - 项目类别:
Lung Macrophage Programming in Acute Lung Injury
急性肺损伤中的肺巨噬细胞编程
- 批准号:
10553701 - 财政年份:2018
- 资助金额:
$ 54.99万 - 项目类别:
Lung Macrophage Programming in Acute Lung Injury
急性肺损伤中的肺巨噬细胞编程
- 批准号:
10094076 - 财政年份:2018
- 资助金额:
$ 54.99万 - 项目类别:
Macrophage Apoptosis in Resolution of Acute Lung Injury
巨噬细胞凋亡在缓解急性肺损伤中的作用
- 批准号:
8528053 - 财政年份:2012
- 资助金额:
$ 54.99万 - 项目类别:
Macrophage Apoptosis in Resolution of Acute Lung Injury
巨噬细胞凋亡在缓解急性肺损伤中的作用
- 批准号:
8460822 - 财政年份:2012
- 资助金额:
$ 54.99万 - 项目类别:
Macrophage Apoptosis in Resolution of Acute Lung Injury
巨噬细胞凋亡在缓解急性肺损伤中的作用
- 批准号:
8661268 - 财政年份:2012
- 资助金额:
$ 54.99万 - 项目类别:
Macrophage Apoptosis in Resolution of Acute Lung Injury
巨噬细胞凋亡在缓解急性肺损伤中的作用
- 批准号:
8297328 - 财政年份:2012
- 资助金额:
$ 54.99万 - 项目类别:
Macrophage Apoptosis in Resolution of Acute Lung Injury
巨噬细胞凋亡在缓解急性肺损伤中的作用
- 批准号:
8830993 - 财政年份:2012
- 资助金额:
$ 54.99万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 54.99万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 54.99万 - 项目类别:
2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
2/2 血管疾病的改善结果 - 主动脉夹层 (IMPROVE-AD)
- 批准号:
10663555 - 财政年份:2023
- 资助金额:
$ 54.99万 - 项目类别:
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
- 批准号:
10643269 - 财政年份:2023
- 资助金额:
$ 54.99万 - 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
- 批准号:
10712202 - 财政年份:2023
- 资助金额:
$ 54.99万 - 项目类别: